Current and historical daily PE Ratio for Circio Holding ASA (
) from 2016 to Jun 13 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Circio Holding ASA stock (OSL:CRNA) PE ratio as of Jun 13 2024 is 0.
More Details
Circio Holding ASA (OSL:CRNA) PE Ratio (TTM) Chart
Circio Holding ASA (OSL:CRNA) PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Total 1285
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Circio Holding ASA PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-13 | At Loss | 2024-04-05 | At Loss |
| 2024-06-12 | At Loss | 2024-04-04 | At Loss |
| 2024-06-11 | At Loss | 2024-04-03 | At Loss |
| 2024-06-10 | At Loss | 2024-04-02 | At Loss |
| 2024-06-07 | At Loss | 2024-03-27 | At Loss |
| 2024-06-06 | At Loss | 2024-03-26 | At Loss |
| 2024-06-05 | At Loss | 2024-03-25 | At Loss |
| 2024-06-04 | At Loss | 2024-03-22 | At Loss |
| 2024-06-03 | At Loss | 2024-03-21 | At Loss |
| 2024-05-31 | At Loss | 2024-03-20 | At Loss |
| 2024-05-30 | At Loss | 2024-03-19 | At Loss |
| 2024-05-29 | At Loss | 2024-03-18 | At Loss |
| 2024-05-28 | At Loss | 2024-03-15 | At Loss |
| 2024-05-27 | At Loss | 2024-03-14 | At Loss |
| 2024-05-24 | At Loss | 2024-03-13 | At Loss |
| 2024-05-23 | At Loss | 2024-03-12 | At Loss |
| 2024-05-22 | At Loss | 2024-03-11 | At Loss |
| 2024-05-21 | At Loss | 2024-03-08 | At Loss |
| 2024-05-16 | At Loss | 2024-03-07 | At Loss |
| 2024-05-15 | At Loss | 2024-03-06 | At Loss |
| 2024-05-14 | At Loss | 2024-03-05 | At Loss |
| 2024-05-13 | At Loss | 2024-03-04 | At Loss |
| 2024-05-10 | At Loss | 2024-03-01 | At Loss |
| 2024-05-08 | At Loss | 2024-02-29 | At Loss |
| 2024-05-07 | At Loss | 2024-02-28 | At Loss |
| 2024-05-06 | At Loss | 2024-02-27 | At Loss |
| 2024-05-03 | At Loss | 2024-02-26 | At Loss |
| 2024-05-02 | At Loss | 2024-02-23 | At Loss |
| 2024-04-30 | At Loss | 2024-02-22 | At Loss |
| 2024-04-29 | At Loss | 2024-02-21 | At Loss |
| 2024-04-26 | At Loss | 2024-02-20 | At Loss |
| 2024-04-25 | At Loss | 2024-02-19 | At Loss |
| 2024-04-24 | At Loss | 2024-02-16 | At Loss |
| 2024-04-23 | At Loss | 2024-02-15 | At Loss |
| 2024-04-22 | At Loss | 2024-02-14 | At Loss |
| 2024-04-19 | At Loss | 2024-02-13 | At Loss |
| 2024-04-18 | At Loss | 2024-02-12 | At Loss |
| 2024-04-17 | At Loss | 2024-02-09 | At Loss |
| 2024-04-16 | At Loss | 2024-02-08 | At Loss |
| 2024-04-15 | At Loss | 2024-02-07 | At Loss |
| 2024-04-12 | At Loss | 2024-02-06 | At Loss |
| 2024-04-11 | At Loss | 2024-02-05 | At Loss |
| 2024-04-10 | At Loss | 2024-02-02 | At Loss |
| 2024-04-09 | At Loss | 2024-02-01 | At Loss |
| 2024-04-08 | At Loss | 2024-01-31 | At Loss |
Circio Holding ASA (OSL:CRNA) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Circio Holding ASA
ISIN : NO0013033795
Compare
Compare
Traded in other countries / regions
CRNA.NorwayTA50.Germany0RIS.UKTRVXO.Sweden IPO Date
2016-07-08Description
Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients. The company's pipeline candidate includes circVec and Mutant KRAS.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers